Non-Motor Symptoms in Parkinson's Disease Study Group
Have questions? Contact the group’s MDS Staff Liaison, Allie Stoffel, at astoffel@movementdisorders.org.
Goals
- To collect new and novel patient and carer reported information on Non-Motor Symptoms (NMS) of Parkinson’s disease from around the world
- To develop a MDS version of a new PD non motor symptoms scale
- To ensure that comprehensive and unified NMS assessments in clinical trials and scientific studies are increasingly used to increase the “real life” value of clinical trials and clinical studies
- To set up and start international cross cultural studies, to improve existing tools for NMS (e.g. NMSS and NMSQ)
- To develop animal models addressing non-motor phenotypes of PD
- To refine, validate and establish non-motor subtypes of PD and related biomarkers
View the group's: |
Ongoing Projects
- Bodily mapping of symptoms and emotions in Parkinson’s disease – Data will be collected from both in-person study visits and online survey.
- Vision in PD – Multicenter collaborative observational, longitudinal follow-up study evaluating the prevalence, severity, and impact of vision disturbances in patients with PD.
- Living with long-term conditions scale - Cross-cultural adaptation and relationship with non-motor symptoms in different populations.
- Review on apathy in PD.
Leadership

Chair
Cristian Falup-Pecurariu
Steering Committe:
Roongroj Bhidayasiri
Juho Joutsa
Walaa Kamel Elsayed
Prashanth Kukkle
Valentina Leta
Irene Malaty
Per Odin
Maria Elisa Piemonte
Raymond Rosales
Delaram Safarpour
Imran Sarker
Anette Schrag
Yoshio Tsuboi
Daniel Weintraub
Getting Involved
In addition to the MDS staff liaison, the Study Group's administrative managers are Lucia Batzu (luciabatzu@gmail.com) and Iulia Murasan (iulia_murasan@yahoo.com).
Themed Subgroups
Published Papers
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease
- Non-Motor Parkinson's Disease
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis
- Non-Motor Parkinson's Disease
Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study
- Non-Motor Parkinson's Disease
Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?
- Non-Motor Parkinson's Disease
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease
- Non-Motor Parkinson's Disease
Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease?
- Non-Motor Parkinson's Disease
The Impact of COVID‐19 on Access to Parkinson's Disease Medication
- Non-Motor Parkinson's Disease
Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS)
- Non-Motor Parkinson's Disease
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
- Non-Motor Parkinson's Disease
Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease
- Non-Motor Parkinson's Disease
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease
- Non-Motor Parkinson's Disease
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
- Non-Motor Parkinson's Disease




